Citadel Advisors’s Amesite AMST Stock Holding History

Citadel Advisors’s Portfolio AMST Stock Details AMST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,992	Closed	-$55.6K	–	12395
2025 Q1	$55.6K	Buy	+22,992	New	+$67.4K	﹤0.01%	12200
2024 Q3	–	Sell	-12,143	Closed	-$37.3K	–	14170
2024 Q2	$37.3K	Buy	+12,143	New	+$36.2K	﹤0.01%	12055
2022 Q4	–	Sell	-1,393	Closed	-$4K	–	14834
2022 Q3	$4K	Sell	1,393 -1,292	-48%	-$7.09K	﹤0.01%	12388
2022 Q2	$15K	Buy	+2,685	New	+$18.6K	﹤0.01%	12488
2021 Q4	–	Sell	-3,963	Closed	-$85K	–	13730
2021 Q3	$85K	Buy	+3,963	New	+$97.2K	﹤0.01%	13016
2021 Q2	–	Sell	-1,134	Closed	-$56K	–	13601
2021 Q1	$56K	Buy	+1,134	New	+$73.6K	﹤0.01%	12846
2020 Q4	–	Sell	-5,546	Closed	-$293K	–	10863
2020 Q3	$293K	Buy	+5,546	New	+$315K	﹤0.01%	8168

Other funds holding AMST

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

ZIG

Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's AMST Position: Q2 2025 in Review

Citadel Advisors sold out of Amesite (AMST) in Q2 2025, closing a stake of 22,992 shares — an estimated $55.6K sold.

Citadel Advisors first reported a position in AMST in Q3 2020 and held it in 7 quarters. The position peaked at $293K in Q3 2020. 11 funds tracked by Wall St. Rank hold AMST as of Q2 2025.

Citadel Advisors reported no remaining Amesite position as of Q2 2025 after selling out during the quarter.
Citadel Advisors sold 22,992 Amesite shares in Q2 2025, an estimated $55.6K.
Citadel Advisors first reported a position in Amesite in Q3 2020 and held it in 7 quarters.
Citadel Advisors's Amesite position peaked at $293K in Q3 2020.
11 funds tracked by Wall St. Rank held Amesite as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.